Aurinia Pharmaceuticals (AUPH) Inventory Average (2021 - 2026)

Aurinia Pharmaceuticals' Inventory Average history runs 6 years deep, the most recent figure standing at $46.0 million for Q1 2026.

• Quarterly Inventory Average rose 7.82% year-over-year to $46.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.0 million (up 7.82% YoY) and the FY2025 annual result came in at $42.5 million, up 7.58% from the prior year.
• Inventory Average was $46.0 million for Q1 2026 at Aurinia Pharmaceuticals, up from $45.2 million in the prior quarter.
• Across five years, Inventory Average topped out at $46.3 million in Q2 2025 and bottomed at $22.8 million in Q1 2022.
• A 5-year average of $36.0 million and a median of $38.8 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2022 — Inventory Average soared 56.49% — and 2024, when it grew 7.47%.
• Aurinia Pharmaceuticals' Inventory Average stood at $25.0 million in 2022, then surged by 44.84% to $36.3 million in 2023, then grew by 7.47% to $39.0 million in 2024, then advanced by 16.09% to $45.2 million in 2025, then grew by 1.79% to $46.0 million in 2026.
• Business Quant data shows AUPH's Inventory Average at $46.0 million in Q1 2026, $45.2 million in Q4 2025, and $45.6 million in Q3 2025.